Antibiotics for treatment of infections caused by gram-positive cocci.
D000617:Aminoglycosides / Q000627:therapeutic use; D000667:Ampicillin / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria; D002511:Cephalosporins / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D003023:Cloxacillin / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D010403:Penicillin Resistance; D010406:Penicillins / Q000009:adverse effects / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D013449:Sulfonamides; D002981:Clindamycin; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D000667:Ampicillin; D008034:Lincomycin; D013752:Tetracycline; D003023:Cloxacillin; D010400:Penicillin G